Article

Differences in the Incidence of Congestive Heart Failure by Ethnicity. The Multi-Ehnic Study of Atherosclerosis

Division of Cardiology, Department of Medicine, The Johns Hopkins University, Baltimore, MD 21287, USA.
Archives of internal medicine (Impact Factor: 13.25). 11/2008; 168(19):2138-45. DOI: 10.1001/archinte.168.19.2138
Source: PubMed

ABSTRACT The relationship between incident congestive heart failure (CHF) and ethnicity as well as racial/ethnic differences in the mechanisms leading to CHF have not been demonstrated in a multiracial, population-based study. Our objective was to evaluate the relationship between race/ethnicity and incident CHF.
The Multi-Ethnic Study of Atherosclerosis (MESA) is a cohort study of 6814 participants of 4 ethnicities: white (38.5%), African American (27.8%), Hispanic (21.9%), and Chinese American (11.8%). Participants with a history of cardiovascular disease at baseline were excluded. Cox proportional hazards models were used for data analysis.
During a median follow-up of 4.0 years, 79 participants developed CHF (incidence rate: 3.1 per 1000 person-years). African Americans had the highest incidence rate of CHF, followed by Hispanic, white, and Chinese American participants (incidence rates: 4.6, 3.5, 2.4, and 1.0 per 1000 person-years, respectively). Although risk of developing CHF was higher among African American compared with white participants (hazard ratio, 1.8; 95% confidence interval, 1.1-3.1), adding hypertension and/or diabetes mellitus to models including ethnicity eliminated statistical ethnic differences in incident CHF. Moreover, African Americans had the highest proportion of incident CHF not preceded by clinical myocardial infarction (75%) compared with other ethnic groups (P = .06).
The higher risk of incident CHF among African Americans was related to differences in the prevalence of hypertension and diabetes mellitus as well as socioeconomic status. The mechanisms of CHF also differed by ethnicity; interim myocardial infarction had the least influence among African Americans, and left ventricular mass increase had the greatest effect among Hispanic and white participants.

0 Followers
 · 
177 Views
  • Source
    • "Although previous studies showed that genetic polymorphisms in the MMP-9 gene apparently have no major effects on the circulating MMP-9 level in healthy white men (Demacq et al., 2006, 2008b), no previous study has examined this possibility in black subjects. Examining this possibility in black subjects is very relevant, because significant interethnic differences exist with respect to genetic background (Lacchini et al., 2010b), risk factors, prevalence, and severity of cardiovascular disease , and black subjects are exposed to increased risk (Mensah et al., 2005; Hozawa et al., 2007; Bahrami et al., 2008; Bibbins-Domingo et al., 2009; Carroll et al., 2009). Moreover, no previous study has examined whether MMP-2 gene variations affect plasma MMP-2 levels in healthy subjects. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Altered matrix metalloproteinases (MMPs) levels are involved in cardiovascular diseases and increased MMP-9 levels enhance the cardiovascular risk in apparently healthy subjects. We investigated the effects of MMP-9 gene polymorphisms and haplotypes on the circulating MMP-9 levels in healthy black subjects and the effects of an MMP-2 polymorphism on the plasma MMP-2 concentrations. We studied 190 healthy subjects, nonsmokers, self-reported as blacks (18-63 years). Genotypes for the MMP-2 C(-1306)T polymorphism and the MMP-9 C(-1562)T, 90(CA)(14-24) and Q279R polymorphisms (rs243865, rs3918242, rs2234681, and rs17576, respectively) were determined by TaqMan(®) Allele Discrimination assay and real-time polymerase chain reaction or restriction fragment length polymorphism. Alleles for the 90(CA)(14-24) polymorphism were grouped as low (L) when there were <21 and high (H) when there were ≥21 CA repeats. The plasma levels of MMP-2 and MMP-9 were determined by gelatin zymography. The software PHASE 2.1 was used to estimate the haplotypes frequencies. Although we found no effects of the MMP-9 C(-1562)T or the Q279R polymorphisms on MMP-9 levels, higher MMP-9 levels were associated with the HH genotype for the -90(CA)(14-24) polymorphism compared with the HL or LL genotypes. Lower MMP-9 levels were found in carriers of the CRL haplotype (combining the C, R, and L alleles for the MMP-9 polymorphisms) compared with the CRH haplotype. Consistent with this finding, the CRL haplotype was more commonly found in subjects with low MMP-9 levels. The MMP-2 C(-1306)T polymorphism had no effects on the plasma MMP-2 levels. Our results show that MMP-9 genetic variations modify MMP-9 levels in black subjects and may offer biochemical evidence implicating MMP-9 in the pathogenesis of cardiovascular diseases in blacks.
    DNA and cell biology 09/2011; 31(4):504-10. DOI:10.1089/dna.2011.1388 · 1.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Disparities persist in cardiovascular disease, and it is difficult to separate socioeconomic status from race/ethnicity or genetic factors. Blacks have more hypertension, with higher cardiovascular morbidity and mortality. Despite high rates of type 2 diabetes and obesity, Hispanics do not appear to have higher cardiovascular mortality than non-Hispanic whites or blacks. South Asians have premature coronary heart disease, with more metabolic syndrome and diabetes. Racial/ethnic pharmacogenetics does not justify withholding appropriate medications. However, pharmacogenetics demonstrates the importance of using starting doses of medications that are ethnic specific. The Agency for Healthcare Research and Quality reports that the uninsured have difficulty accessing care, which may lead to delayed diagnosis and longer hospitalizations. Minority providers may positively affect the health of an increasingly diverse population.
    Current Cardiovascular Risk Reports 05/2009; 3(3):187-193. DOI:10.1007/s12170-009-0030-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: With globalization and transnational migration, there is an increasing need for health systems in destination countries to consider the healthcare needs of diverse immigrant populations. This article reviews the literature on cardiovascular disease and its risk factors in Somali women in the diaspora. Although we found no studies on cardiovascular disease per se, the little extant research demonstrates that Somali women are exposed to multiple risk factors for cardiovascular disease. This important area of research may have been neglected due to an inordinate focus on maternal and reproductive health. We call for a more inclusive approach to Somali women’s health that takes into account social and cultural contexts of women’s lives while addressing health and illness experienced across the lifespan.
    Current Cardiovascular Risk Reports 06/2012; 6(3). DOI:10.1007/s12170-012-0233-5
Show more

Preview

Download
1 Download
Available from